Answer
Impaired kidney function has been reported in bone marrow transplant patients who received high-dose intravenous melphalan hydrochloride followed by ciclosporin to prevent graft-versus-host disease.
Sources for this answer
- Melphalan 50 mg Powder and Solvent for Solution for Injection/InfusionAspen · emc · SmPC §4.5 Interaction with other medicinal products · Version 8Document updated
Sources checked